Director Clinical Pharmacology
AstraZeneca, United Kingdom
Dr. Andy Sykes, PhD, is currently a Director of Clinical Pharmacology at AstraZeneca, UK working in the disease area of oncology. He earned his PhD from the University of York, England investigating the absorption and metabolism of peptide pro-drugs. Prior to starting at AstraZeneca he worked at Takeda Cambridge, UK as a DMPK Project Leader working on various neuroscience and inflammation projects. He has published several original research articles and presented at both national and international pharmacology meetings. Dr. Sykes has organised numerous scientific meetings as a committee member of The Society for Medicines Research.